Pharmaceuticals in Developing and Emerging Economies
Production, Innovation, and Access to Medicines in the Wake of TRIPS
Co-sponsored by the
University of Hyderabad, India and
Deakin University, Melbourne, Australia
Friday 17 September 2010 - Sunday 19 September 2010
Venue: University of Hyderabad, India
The conference examined the state of drug production and innovation in the global South in the wake of the implementation of TRIPS-mandated intellectual property rights. The interface between industrial capabilities, and access to essential medicines, is a second major theme. The aim is to provide a landmark assessment of these critical areas in global health and development.
This event provided a unique opportunity for researchers, policy makers, public health advocates, and industry representatives to deliberate on the economics and politics of the pharmaceutical industry and access to medicines, across the developing and emerging economies.
The Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement imposes global minimum standards for intellectual property protection to be phased in across all members of the World Trade Organization (WTO). The stated purpose is to improve the conditions for innovation and technology transfer – for the benefit not only of incumbent industry leaders but also developing and emerging economies.
It is not evident however that the overall gap in the global pharmaceutical industry between developed and developing countries has diminished. The global drug market and global health research remain dominated by North America, Europe and Japan. These regions account for around 75% of global sales and more than 90% of global health-related research. From this perspective, TRIPS would seem to impose a 'one size fits all' model on the developing countries, notwithstanding different health needs or stage of economic development.
Yet firms and research organisations in some emerging economies have established a significant presence in global innovation and production networks. India is the outstanding case and countries such as China, Brazil, Cuba, Thailand and South Africa also have notable capabilities. But there is scarce systematic knowledge of the present state and future prospects of pharmaceutical production and innovation across the global South – a deficiency addressed by this conference. Among the papers presented will be detailed studies of the impact of TRIPS on the pharmaceutical industry and public health in particular countries in all major regions of the developing world.
Professor D. Balasubramanian
Professor D Balasubramanian is the Director of Research at L. V. Prasad Eye Institute, Hyderabad, India. His research interests are in eye biology, and at the LVPEI he conducts and directs basic and translational research into treating eye disorders. Earlier, he was Director, Centre for Cellular and Molecular Biology, Hyderabad, and Professor and Dean, University of Hyderabad. As the first Chairman of the Biotechnology Advisory Board of the State of Andhra Pradesh, he helped set up the Biotech Park (Genome valley) near Hyderabad. He was until recently President of the Indian Academy of Sciences, and is currently Secretary General of the Academy of Sciences for the Developing World (TWAS), Trieste, Italy.
Professor Bhargava P. M. Professor P. M. Bhargava is a legendary figure in Indian science and science policy. He was the founding director of the renowned Centre for Cellular and Molecular Biology (CCMB) in Hyderabad and is widely regarded as the architect of modern biology and biotechnology in India. He was previously Vice-Chairman of the National Knowledge Commission.
Dr Mira Shiva
Dr. Mira Shiva is Public Health Physician involved in issues of Gender, Health and Equity, Rational Use of Medicines, Rational Drug Policy, Health and Public Policy for over 30 years. Dr. Shiva is also the Coordinator, Initiative for Health and Equity in Society, Founder Coordinator and presently coconvenor All India Drug action Network (AIDAN). She is also the founder member and presently steering Committee member of People's Health Movement. Dr Shiva is also the founder member, former Chairperson and presently Advisory Committee member of Health Action International-Asia Pacific. She is also the founder member and Coordinating Committee member Doctors for Food and Biosafety, and also part of Third World Network, South Asian Focal Point for International Peoples Health Council and member Central Ethical Committee on Biomedical Research and member of Central Social Welfare Board. Dr Mira Shiva was also the former chairperson and Advisory Council member of Health Action International Asia -Pacific (HAIAP) and also founding member of National working Group on Patent Laws.
James Love is the Director of Knowledge Ecology International (KEI). Mr. Love is also the U.S. co-chair of the Trans-Atlantic Consumer Dialogue (TACD) Intellectual Property Policy Committee, chair of Essential Inventions, an advisor to the X-Prize Foundation on a prize for TB diagnostics, and a member of the UNITAID Expert Group on Patent Pools, the MSF Working Group on Intellectual Property, the Stop-TB Partnership working group on new drug development, and the Internet Governance Forum (IGF) Dynamic Coalition on Open Standards. He advises UN agencies, national governments, international and regional intergovernmental organizations and public health NGOs, and is the author of a number of articles and monographs on innovation and intellectual property rights. In 2006, Knowledge Ecology International received a MacArthur Award for Creative and Effective Institutions. Mr. Love was previously Senior Economist for the Frank Russell Company, a lecturer at Rutgers University, and a researcher on international finance at Princeton University. He holds a Masters of Public Administration from Harvard University's Kennedy School of Government and a Masters in Public Affairs from Princeton's Woodrow Wilson School of Public and International Affairs.
Dr Usha Ramanathan
Dr Usha Ramanathan is an internationally renowned expert on law and poverty. She is a research fellow at the Centre for the Study of Developing Societies, teaches environmental law, labour law and consumer law at the Indian Law Institute and is a regular guest professor at many universities around the world. Dr Ramanathan is a frequent adviser to non-governmental and international organizations. She is, for example, a member of Amnesty International's Advisory Panel on Economic, Social and Cultural Rights, and has been called upon by the World Health Organisation as an expert on mental health. Dr Ramanathan has published extensively in India and abroad and is the South Asia Editor of the Law, Environment and Development Journal. Her research interests include human rights, displacement, torts and environment. In particular, she has devoted her attention to the Bhopal gas disaster, the Narmada valley dams and the issue of slum evictions in Delhi.
Mr Anand Grover
Mr Anand Grover is Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health appointed by The United Nations Human Right Council on 1 August 2008. Mr Grover is Director of the Lawyers Collective HIV/AIDS in India, having offices in Mumbai, Delhi, and Bangalore which he co-founded in 1981 with Ms. Indira Jaising, The Unit dealing with HIV/AIDS was established in Mumbai in 1998. Anand Grover is a pioneer in the field of HIV and has handled several hundred HIV/AIDS related litigations in India. He appeared in the first HIV case relating to the HIV activist, Dominic D Souza, The Lucy D' Souza case, challenging the isolationist Goa Public Health Amendment Act. He also fought the first case on blood transfusion in the Calcutta High Court, P v. Uol as well as successfully arguing against the patenting of anti-AIDS drug Nevirapine Hemi-hydrate. Mr. Grover has also appeared in several well known cases as lead counsel in various public interest and human rights matters, including the first HIV case in India relating to employment law, MX v. ZY, the Bombay Pavement Dwellers case, several environmental cases including the Bhopal Gas Disaster case, the Goa Zuari Agrochemicals case, various sexual harassment cases including the India Air Hostess cases, the Shehnaaz Mudhbatakal v. Saudi Arabian Airlines, and various animal rights cases, such as the Camel case, the Kamani Tubes Ltd. Case, and the Garware Nylons Case. He has also acted as an advocate in many important cases regarding the right to marry and the rights of sex workers, such as the Mr. X v. Hospital Z case and the Mumbai Bar Dancers case. He serves as member of various renowned health boards. He was a member of the drafting group of the International Guidelines on Human Rights & HIV/AIDS and is currently a member of the Reference Group on Human Rights to Peter Piot, Executive Director, UNAIDS. He is a National Advisory Board Member of International AIDS Vaccine Initiative, a member of the World Care Council, a member of the Board of the International Council of AIDS Service Organizations (ICASO), a member, National Board, AVAHAN, the India AIDS Initiative, Gates Foundation, a member of the Core Group of NGOs representatives in the National Human Rights Commission of India and the member of the National Advisory Board on HIV and AIDS set up the Prime Minister of India.
|Papers in the conference|
PPN 002- Export Potential of Herbal and Medicinal Plants as a Sourse of Alternative Medicine
Asst. Professor Shaili Vadera, Ms. Payal Srivastav & Associate Professor Vinod Singh*Amity Business School, Amity University, Lucknow Campus, India & * Department of Economics, Lucknow University
Bio - Asst. Professor Shaili Vadera, Ms. Payal Srivastav & Associate Professor Vinod Singh
Shaili Vadera is Assistant Professor at Amity Business School, Amity University Uttar Pradesh, Lucknow. Her qualifications include Post Graduate Diploma in Business Management, M.A.(Economics), B.Sc. (Life Sciences), UGC NET June 2009, and presently pursuing Ph.D. from Department of Economics, Lucknow University. She has 7 years of Academic and industry experience and has published several papers.
Payal Shrivastava graduated B.Com(computer application) from V.I.T. University . Currently, doing M.B.A( Agribusiness) from Amity University Lucknow Campus.
PPN 005 - Knowledge management: Aspects related with Drug Pricing in India
Associate Professor Avinash Ganbote & Assistant Professor Neelkanth Dhone
Abstract:Health and its value is issue of debate all over world in last decade. Demand and supply sides of healthcare and its microeconomic evaluation is important issue of various aspects of intellectual property and its commercialization in terms of Intellectual Property Rights (IPRs). Establishment of market equilibrium as a result of demand and supply of health inputs and its monitoring mechanism is the area of study which is fast emerging in terms of health economics. Some factors which play important role in health economics are government intervention, uncertainty about patient outcome and financial concerns. Drug research and its actual cost in this equilibrium is debatable issue in international front. India as signatory to WTO is affected to some extend by this relationship between commercialization of patents and deadweight loss incurred due to IPRs and its resulting economic inefficiency. Imbalance of information and its implications in provision of drug cost in terms of patented and proprietary medicine is the impending factor leading to economic studies of this particular subject. Complex demand structure is observed for pharmaceutical goods due to presence of therapeutic substitute of drug and practice of drug manufacturer to differentiate their products through the use of trade marks and advertising. If patents are protected; the patent holder has monopoly for the chemical entity, but still competes with producers of therapeutic substitute. This makes TRIPs Flexibilities as important factor to solve impending issues related with availability of medicine in developing countries. Attempt is made in this paper to comment on issues pertaining to developing countries, particularly India.
Bio -Associate Professor Avinash Ganbote & Assistant Professor Neelkanth Dhone
Dr Avinash Ganbote completed his graduation in Pharmaceutical Sciences (B.Pharm), Post Graduation (M.B.A.) and Doctorate in Management Studies (Ph.D.) from University of Pune, India. His area of specialization is Marketing Management; Organizational Management and Economic Environment of Business .He has teaching experience of about 17 years in Pharmacy and Management schools. Presently working as Associate Professor in Management Institution affiliated to Pune University, teaching subjects like Managerial Economics, Business Policy and Strategic Management and Project Management. He is interested to work in the area of Health economics so as to contribute positively in setting drug pricing models equally catering needs of Innovative entrepreneurs and availability of essential medicines at right price. He is life member of Professional organizations like Indian Pharmaceutical Association (IPA), Association of Pharmaceutical Teachers of India (APTI).He is member and Board of Director of Rotary club undertaking various social projects for local community.
Neelkanth C. Dhone is an engineering graduate with mechanical as specialization. Then completed post graduation in Master of Business Administration with Marketing as core and Production as dual specialization. Currently he is working as faculty with Shivnagar Vidya Prasarak Manadal's Institute of Management. Baramati,Dist Pune, India. He is having total five years of experience in teaching, with good command in Basics of marketing, Retail Management, Services Management, and Supply chain management. In addition to that he got registered for Ph.D programme in National Institute of Industrial Engineering. Mumbai, which is of international repute. He has presented papers in various national and international conferences. He has also participated in two A.I.C.T.E sponsored Q.I.P programme.
PPN 006 - Need to Reframe Drug Prices Control Order
Mr Amit D. Arkad
Bio - Mr Amit D. Arkad
Amit Arkad is a final year student of Pharmacy in Bombay College of Pharmacy. His research interest includes pharmacoeconomics studies and Intellectual property rights-specifically patents. He intends to pursue masters degree in Innovation management. He is a member of Indian Pharmaceutical Association and Drug Information Association.
PPN 007 - Product Patents and Access to Medicines: A Critical Review of the Implementation of TRIPS Patent Regime
Mr K M Gopakumar
Bio -Mr K M Gopakumar
Legal advisor and Senior Researcher with the Third World Network(TWN). Educational qualifications : LL.B, LL.M (International Law), LL.M (IPR and Human Rights) and M.Phil (International Law). Since 1997 working on issues related to the implementation of TRIPS patent regime and its implications on access to medicines. Some select publications.
PPN 008 - Access to Medicines in Developing Economies under Competition Law
Dr. Tu Thanh Nguyen
Abstract:IPRs are an important incentive and reward for innovation and the commercialization of such innovation. The protection of IPRs has now been globalized under the minimum standards established by the TRIPS Agreement. However, the protection and enforcement of IPRs should benefit both innovators and innovation users "in a manner conducive to social and economic welfare" by creating balanced rights and obligation among these "stakeholders". The TRIPS Agreement and other international intellectual property conventions contain flexibilities that may facilitate access to medicines by developing countries. One such flexibility is the use of domestic competition law. Developing countries have rarely applied domestic competition law to promote access to IPRs and patented medicines. This is due to many reasons, especially the under-development of competition law in developing countries and the complexity of the interface between IPRs and competition law. It appears that the developing world is trying to use public-health related flexibilities to increase access to medicines. However, such limited flexibilities alone cannot solve all of the issues relating to access to medicines and medical devices. In May 2008, the WHO adopted its global strategy and plan of action on public health, innovation and intellectual property, which encourages and promotes the use of competition law and policy in order to improve availability and affordability of medicines. Therefore, the purpose of this paper is to investigate, through a handful of relevant cases in developing countries, whether and to which extent these countries can adopt and enforce domestic competition law in order to promote access to medicines under the support of competition flexibilities in the TRIPS Agreement.
Bio - Dr. Tu Thanh Nguyen
Dr. Tu T. Nguyen specializes in business law, including IPRs, competition law, WTO law and banking law. He has had 46 publications. He is currently Lecturer of Laws at the Ho Chi Minh City School of Law (Vietnam). He was a researcher and lecturer at the Faculty of Law, Lund University (Sweden); a trainee at the WTO (Switzerland); a scholarship holder at the Max Planck Institute for Intellectual Property, Competition and Tax Law (Munich, Germany); a visiting scholar at the Suffolk University School of Law (Boston, MA, US); and a visiting researcher at the Faculty of Law, Copenhagen University (Denmark).
PPN 009 - Providing Essential & Cost Effective Medicines to the Poor –A Global Perspective
Mr Chakrapani Kambhampati
Bio -Mr Chakrapani Kambhampati
Currently working with Mylan-Matrix (Mylan is the world's third largest producer of generic and specialty pharmaceuticals & Mylan is the Second-largest Generic Pharmaceutical Company in the United States with a global commercial footprint that spans more than 140 countries and territories). Currently I am working as a Deputy Manager with Mylan-Matrix and previously worked with Dr Reddy's Laboratories Limited in Global Quality. Earlier to that, worked for Reputed Companies in Formulations.
10 years of experience in Pharma Industry in different capacities in Mktg, Quality Mgmt & Operations with globally reputed Pharmaceutical Companies. Trained 400- 500 people voluntarily (Fresh out of college who are entering the Pharma Industry) on different topics to enhance their knowledge levels so as to empower them and to share the knowledge what I have & to share the Learnings from the Industry.
PPN 010 - IPR In Indian Pharmaceutical Sector
Mr.Hirak V.Joshi, Mr Thakor R.S & Mr Patel J.K
Bio - Mr.Hirak V.Joshi, Mr Thakor R.S & Mr Patel J.K
Hirak Joshi is a lecturer working at Nootan Pharmacy College, visnagar affiliated to hemchandracharya North Gujarat University, Patan and Gujarat Technological University Ahmedabad. He is also doing Ph.D at Jodhpur national university, Jodhpur and interested in research in Pharmaceutical analysis and method development as well as in study of impurity profile. He is engaged in academic field from last four years.
Mr.Rashmin Thakor is a lecturer working at Nootan Pharmacy College, visnagar affiliated to Hemchandracharya North Gujarat University, Patan and Gujarat Technological University Ahmedabad. He is also doing Ph.D at HNGU Patan. Interested in research in Pharmaceutical Technology and nanotechnology. He is engaged in academic field from last four years.
Dr.J.K.Patel is a Professor and Principal, Nootan Pharmacy College, Visnagar-384315, Gujarat, India. He has more than 14 years of academic and research experience, has published more than 140 research and review papers in international and national journals, and has presented more than 128 research papers at various international and national conferences as author and coauthor. Dr. Patel has guided 38 M Pharm students for dissertation work and 28 students are currently pursuing their PhDs under his guidance. Recently his research project recommended for Fast Track Young Scientists-2008, by Department of Sciences and Technology, Government of India, New Delhi worth of Rs 19.40 Lacs.
PPN 013 - Assessing the impacts of Herbal Medicinal Products Research outcomes in Nigeria (A Dilemma of Universities Social Responsibility and Public Beuracracy)
Mr Hamidu Oluyedun
Keywords: herbal medicinal products; health care institutions; safety and efficacy; research outcomes, primary health care, and needs.
Bio - Mr Hamidu Oluyedun
Born on 13th February 1961 in Ibadan, Nigeria. Graduated as a Pharmacist in 1989, Second degrees in Human Nutrition(1998) and Sociology(2005). Part I fellowship in 2006. An Instructor/Facilitator, Guest lecturer in Schools of Hygiene/Nursing.
PPN 014 - TRIPS and the Global Pharmaceutical Market
Associate Professor Alluri V. N. Varma & Associate Professor Y.Rama Krishna
Bio - Associate Professor Alluri V. N. Varma & Associate Professor Y. Rama Krishna
Dr.Alluri V. N. Varma is an Associate Professor in Economics in the P.G.Courses & Research Centre at D.N.R.College, Andhra Pradesh, India.
Dr Y.Rama Krishna is an Associate Professor in Economics in the P.G.Courses & Research Centre at D.N.R.College, Andhra Pradesh, India.
PPN 015 - Trade and Access to Health in EMRO Countries: Current Status and Future Outlook.
Dr Mohamed A Eldawy, Ph.D.,
A)-An analysis of the IP regimes in place in each country of the EMRO region and their implications regarding access to medicines and health technologies that cover:
B)-Identification of priority countries in the region which need assistance in this area, outlining the nature of this assistance in the technical directly trade related as well as in the indirectly trade related scientific/technological domains. Also identification of relevant institutions and researchers in each of these countries which can help provide real life solutions to face the challenges imposed by globalization.
C)-Providing an implementable time phased plan of action commensurate to the specific needs of each country, thus moving from words to deeds. The proposed country specific action plans delineate the rational, aims and purpose, role and functions, strategic directions of the work to be done by Ministries of health and other stakeholders during 2011and 2012 in order to materialize outcomes of the 63rd World Health Assembly(May 2010, Geneva) focusing on resolutions addressing its agenda item titled " Public health, innovation and intellectual property:global strategy and plan of action".
Bio - Dr Mohamed A Eldawy, Ph.D.,
Mohamed A Eldawy, B Pharm.Sci.(Cairo Univ.-1960).-M Sc. (Alexandria Univ.)-Ph.D (Univ. of Illinois, Chicago, USA).Professor and founding Dean, Faculty of Pharmacy, Tanta Univ. , Tanta, Egypt. Consultant for (several local, regional (EMRO"WHO" & MENA) and international healthcare products/services firms/institutions/organizations providing training and capacity building programs addressing their regulatory, scientific, technological, R&D, QA and trade-related IP needs. Teaching and research healthcare product's QC/QA and evidence based computer aided drug design and discovery.
PPN 019 - Pharmaceutical Patents, Public Health and Access to Essential Medicines: Indian Patent law in post – TRIPS context
Mr Pawan Kumar Pandey
No issue, Patents encourage industries to engage in capital-intensive R&D because of getting option of charging monopoly prices and reaping high profits. But, as a reasonable consequence, that very monopoly prevents generic manufacturing and affects the prices and availability of the finished drugs in market. TRIPS gives considerable importance to public health, social, and economic concerns. It provides, the protection of intellectual property rights shall promote technological innovation and the transfer of technology "in a manner conductive to social and economic welfare, and to a balance of rights and obligations." Appropriate measures may be taken to prevent abuse of intellectual property rights as long as they fall within the provisions of TRIPS. Instead, the TRIPS Agreement has come under fierce criticism because of the effects that increased levels of patent protection will have on drug prices.
The most recent three amendments to the Indian Patents Act, which have introduced a TRIPS consistent patent regime in the country, were brought about in the backdrop of intense debates that were focused on the need to establish a balance between the rights of the patent holders and the interests of the public at large. By purposely excluding pharmaceutical products from patent protection for more than three decades, India became a world leader in high-class generic drug manufacturing. But India's becoming a member of the GATT /WTO, compelled it to once again grant patents on pharmaceutical products. From the perspective of millions suffering worldwide from life-threatening diseases, many of whom were previously benefited from the low-cost products of India's blooming generic drug manufacturing industry, the introduction of a pharmaceutical product patents regime in India can obviously be viewed as an international healthcare catastrophe.
The present article aims to critically analyse the provisions of the India's Patents Act, 1970 (2005) as far as they relate to the Pharmaceutical innovations with a view to trace the shift in Indian Patent law in post – TRIPS context. Attempt has also been made to investigate as to how, Indian Patent system as a successful intellectual property regime, has stricken a balance between creating incentives for innovation and protecting citizens' access to essential medicines. Due reflection has also been made on recent judicial decisions from the Indian Courts viz., Cases involving Novatis, Roche and Bayer etc.
Bio - Mr Pawan Kumar Pandey
Pawan Kumar Pandey has previously served as Lecturer in Law at University of Delhi and National Law University, Jodhpur. He has done his B.Sc. from Puranchal University and has taken his LL.B. and LL.M. degrees from Banaras Hindu University. He has written his LL.M. dissertation on the topic "Infringement of Copyright and Moral Rights." He is pursuing his Ph.D. on the topic "TRIPS Compliance of the Product Patent Regime in India with special reference to Pharmaceutical Products" from Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow. He was recipient of UGC Merit Scholarship during LL.B. studies and Government of India National Scholarship during LL.M. studies. He has been actively involved in research and writings in the field of Intellectual Property Law. He has been member of Chair in IPR at the National Law University Jodhpur established by Ministry of Human Resource Development, Government of India. He has also coordinated a National workshop on Copyright and has presented research papers at several national conferences and seminars. In May 2008 he was invited by Albert-Ludwigs University, Freiberg, Germany to present a research paper in "Indo-German Conference on IPR". During his visit to Germany he also participated in round – table meet on "Innovation in India: Current Policy and Trends" organized by the BMW Foundation. Again, he visited the European Patent office (EPO), Munich, and participated in the deliberations on "EC-ASEAN Intellectual Property Rights Co-operation Programme". His special areas of interest are Intellectual Property Law, Information Technology Law, World Trade and WTO.
PPN 020 - Public funded research. What can tech transfer managers contribute to enhance access to medicine?
Dr. Christiane Fischer, Prof. Dr. Christine Godt, Dr. Peter Tinnemann, & Dr. Christian Wagner-Ahlfs,
Bio - Dr. Christian Wagner-Ahlfs, Dr. Christiane Fischer, Prof. Dr. iur. Christine Godt & Dr. Peter Tinnemann
Dr. Christian Wagner-Ahlfs, PhD: chemist, Executive Director at BUKO Pharma-Kampagne Germany. Working areas: access to medicine and patents. Coordinating the research project med4all.org. Chair of Health Action International HAI Europe executive board. Until 2008 coordinating HAI global member activities related to "WHO Intergovernmental Working Group on Innovation, Public Health and Intellectual Property rights".
Dr. Christiane Fischer MD, PhD: Executive Director at BUKO Pharma-Kampagne Germany. Working Areas: access to medicine, patents, TRIPS agreement. Board member of the network Action against AIDS Germany.
Prof. Dr. iur. Christine Godt, lawyer, Professor of European and International Law at the University of Oldenburg, Director Hanse Law School. Her special research interest is IP-law. Her focus in the "Equitable Licenses-Project" is the design of policies for universities and congruent contract clauses which assure the goals of equitable licensing.
Dr. Peter Tinnemann, MD, MPH, PhD is physician and health researcher at the Charité Universitätsmedizin Berlin, with a particular interest in social medicine, access to health care and health in a globalizing world. He holds a Master in Public Health from Cambridge University and has more than 10 years work experiences with various international humanitarian aid organisations.
PPN 021 - Comparative analysis of Indian pharmaceutical and medical devices sector
Mr Dinar Kale
Bio - Mr Dinar Kale
Dinar Kale currently works as a Lecturer in International Development and Innovation at the ESRC Innogen Centre, The Open University. Dinar holds an MSc in Organic Chemistry (University of Pune), an MBA in Marketing Management (University of Pune) and a PhD (The Open University Business School). He has conducted significant research on evolution of capabilities in the Indian pharmaceutical industry, particularly impact of regulation on capability development, technology and innovation management in Indian pharmaceutical firms. His main research interests include the impact of regulation on delivering health in developing countries, KM in life sciences industries, and innovation management. His work has been published in the reputed journals such as Technology Analysis and Strategic Management, Industry and Innovation, Industrial and Corporate Change and British Journal of Management.
PPN 029 - Operational and R&D Efficiencies of Indian Pharmaceutical Firms in Product Patent Regime
Ms Ishita G. Tripathy*, Professor Surendra S. Yadav** & Dr Seema Sharma***
Empirical results of this paper indicate that there is a high positive correlation between operational efficiencies and R&D efficiencies. Operationally efficient firms as compared to inefficient ones are bigger, older, more R&D-intensive and are recipients of Foreign Direct Investment (FDI). R&D efficient firms in comparison to R&D inefficient firms are bigger, more export-oriented and are recipients of FDI for their R&D activities. The research findings of this study can help the pharmaceutical industry to formulate appropriate action plans to enhance the pharmaceutical firms' operational and R&D efficiencies in the new patent era.
Key Words: Product patent regime, operational efficiency, R&D efficiency, pharmaceutical firms, India
Bio - Ms Ishita G. Tripathy, Professor Surendra S. Yadav & Dr Seema Sharma
Ishita G. Tripathy, a post-graduate in Economics and Population Studies, is pursuing her Ph.D. at the Department of Management Studies, Indian Institute of Technology Delhi, India. Her areas of interest include international finance and development economics.
Surendra S. Yadav is currently Professor of Finance and Head of the Department of Management Studies at the Indian Institute of Technology Delhi, India. He teaches Corporate Finance, International Finance, International Business, and Security Analysis and Portfolio Management. Dr. Yadav has been a Visiting Professor at the University of Paris, Paris School of Management, INSEEC Paris, and the University of Tampa, USA. He has published nine books and contributed more than 115 papers to research journals and conferences. He has also contributed more than 30 papers to financial/economic newspapers.
Seema Sharma is Assistant Professor in the Department of Management Studies at the Indian Institute of Technology Delhi (IIT Delhi), India. Her areas of interest include marketing research, statistical analysis and economics. The major area of research, among others, centres on productivity analysis. Dr. Sharma has participated and presented her research in many national conferences. She has also presented papers in international conferences in United States (University of Miami) and Australia (University of Queensland). She teaches courses in the area of statistics and economics.
PPN 030 - Human Rights, TRIPS and Access to Medicines in India
Ms BA Shilpa
With the implementation of TRIPS there is clash between patent system and the access to essential drugs especially for the poor. A "national health disaster" was anticipated by the Indian Drug Manufacturers Association (IDMA) as a result of the implementation of the TRIPS Agreement in the country, where only 30 percent of the population can afford modern medicines in spite of the fact that drug prices in India are one of the lowest in the world. Comparison of prices of drugs between India and countries where patent protection exists indicated that in some cases they are up to 41 times costlier in countries with patent protection.
Bio - Ms BA Shilpa
Ms BA Shilpa is presently working as Lecturer, Dept. Of Political Science, Maharani's Arts, Commerce & Management College for Women, Bangalore, India. She completed her Master of Arts (Political Science) from University of Hyderabad. Her areas of interest are International Relations, Sustainable Development, Human Rights & Public Policy.
PPN 034 - Patents and Access to Medicines:The Politics of AIDS Treatment in Brazil
Dr André de Mello e Souza
Bio - Dr André de Mello e Souza
André de Mello e Souza is a researcher at the Institute for Applied Economic Research, a governmental think-tank which guides and evaluates public policies in Brazil. He previously worked as a university professor, and holds a doctorate in Political Science from Stanford University, USA. His publications concern patents and health.
PPN 036 - 'The political domain of Global Health Governance: Norms, Tensions and Challenges'
Ms Belinda Townsend
Although the landscape of Global Health Governance has come to be recognised as a legitimate policy domain, evident in scholarly journals such as Global Public Health, Globalization and Health, Global Health Governance and Global Health Action, this political domain is fraught with tension between the competing perspectives. 'Good governance' is an ideologically laden concept, perceived differently in the perspective of democratic principles and global justice than in debates on security and cost effectiveness. Legitimacy in this domain is also contested; framed in democratic principles and equality or couched in the ability to deliver and achieve goals. This analysis identifies key issues regarding equity, accountability and legitimacy in the global health domain.
Bio - Ms Belinda Townsend
Belinda Townsend is a PhD scholar, School of International and Political Studies, Deakin University, Australia. The author has completed a BAppSc(HealthSc) and BA(Hon) at Deakin University.
PPN 043 - Patent Battles in India and National Flexibilities-What is in Stake for consumers?
Associate Professor Lalitha Narayanan
Bio - Associate Professor Lalitha Narayanan
N.Lalitha, is a Ph.D in Economics and works as an Associate Professor at Gujarat Institute of Development Research, a premier social science research institute in India. Her research focuses on issues relating to access to medicines in developing countries that arise from strengthening intellectual property rights particularly in the field of pharmaceuticals.
PPN 044 - Business strategies for SME pharmaceutical companies in the Product patent era
Professor G.Mohan & Associate Professor Nirmalya Bagchi
Hyderabad is well-known as a Bulk Drug (API) producing centre. This cluster has nearly 250 SMEs producing over 200 different APIs and intermediates. These SMEs not only supply APIs and intermediates to the bigger formulation companies in India, they also export a significant fraction of their production.
The growth and evolution of the API industry in Hyderabad happened during the process patent era of the '80s and '90s. The implementation of the product patents as a part of TRIPs from 2005 onwards has brought about a radical change in the business strategies of the various industry players, particularly the large generic companies in India.
The business strategies of the generic companies are changing so as to adapt to the product-patent regime. The generic companies are adapting in a variety of ways for example, enhancing the investments in R & D for new drug discovery, filing ANDAs for drugs going off-patents, Para IV filings under Hatch Waxman Act, strategic alliances for contract manufacturing of authorised generics, merging with larger MNCs etc. This has a direct bearing on the APIs and intermediate suppliers to them, namely the SMEs
This paper will take a sample of SMEs from the Hyderabad cluster. Through case studies will identify the challenges faced by them particularly in the wake of patents and tightening regulations. The paper will propose strategies the SMEs can adopt so as to become competitive and innovative under the new regime.
Bio - Professor G.Mohan & Associate Professor Nirmalya Bagchi
Mr. Gopalratnam Mohan, currently Professor, Information Technology Area, Centre for Innovation and Technology, ASCI, is a B.Tech from Banaras Hindu University, Varanasi and an MBA from Xavier Institute of Management, Bhubaneswar. He has over 20 years of industry experience in leading consulting organizations, Tata Consultancy Services and MECON Ltd. His area of interests include application of IT and Internet to Business, Strategic management and Innovation Management.
Dr. Nirmalya Bagchi, currently Associate Professor, Technology Policy, Management and Innovation Area, Centre for Innovation and Technology, ASCI, is an M.B.A. and Ph.D in Business Management in the area of Information Management, from University of Calcutta. Dr. Bagchi has about 8 years of teaching experience and research experience in various management institutions. He has also authored several academic papers and books. His area of interests include Innovation management, Technology and Science Policy. Decision Support Systems.
PPN 045 - Successful Business Models of Affordable Innovation in Indian Bio-pharmaceutical and Healthcare Sectors
Dr S.Balasubrahmanyam*, Dr Prasad Kaipa*, Dr. Prasad VCS*, Mr Sourabh Gargav** & Mr Suresh MV*
Bio -Dr S.Balasubrahmanyam, Dr Prasad Kaipa, Dr. Prasad VCS, Mr Sourabh Gargav & Mr Suresh MV
S. Balasubrahmanyam is currently a post-doctoral fellow at the Centre for Leadership, Innovation, and Change, Indian School of Business, Hyderabad. He holds a bachelor's degree in mechanical engineering, a master's degree in marketing management and a doctoral degree in strategic management from Indian Institute of Science, Bangalore.
Prasad Kaipa is the executive director of the Centre for Leadership, Innovation, and Change, Indian School of Business, Hyderabad. He holds both masters' and doctoral degrees in physics. He has two decades of consulting experience with more than 100 CEOs and other senior level managers of world-class organizations. He was an international marketing manager for Apple Computers and was a research fellow at Apple University.
Prasad VCS is the advisor for Biocon Cell for Innovation Management at the Centre for Leadership, Innovation, and Change, Indian School of Business, Hyderabad. He holds Master's and Doctoral Degrees in Metallurgical Engineering from Indian Institute of Science, Bangalore and Indian Institute of Technology, Kanpur respectively. He has nearly four decades of industrial experience, right from Bharat Electronics Limited to Tata Consultancy Services as a researcher, at various levels.
Sourabh Gargav is currently working as a Research Assistant in the Biocon Cell for Innovation Management (BCIM) at the Centre for Leadership, Innovation and Change (CLIC) of the Indian School of Business (ISB), Hyderabad. He possesses degrees in Public Policy, Patent Laws, and Microbiology. He has a couple of years of, both, research and industrial experience.
Suresh MV is a research assistant at the Centre for Leadership, Innovation, and Change, Indian School of Business, Hyderabad. He has a master's degree in Statistics – Operations Researcj from Central University of Hyderabad. He previously worked with Indian Statistical Institute, Kolkata as a statistical trainee.
PPN 049 - Economic Implications of Pharmaceutical Manufacturing Industry in India
Associate Professor V. Y. John
The Indian pharmaceutical industry is a significant case of a manufacturing industry contributing to the economic growth in India in a comprehensive sense. Companies like Ranbaxy Laboratories, Dr.Reddy's Laboratories, Aurobindo Pharma, Lupin Laboratories, Cipla and Sun Pharmaceuticals are some of those which have pursued inorganic growth routes as can be noted from the remarkable acquisitions or mergers which have taken place recently. It is observed that there is an exponential growth in the size of the operations, number of countries to which exports are being made and different segments of products catering to diseases like AIDS, cardiovascular, gastro enteric, carcinogenic and lifestyle diseases. The state of the art technology that is adopted by the companies to incorporate effective quality in the process of manufacturing speaks volumes of how Indian companies have grown to meet the expectations of the global market.
Key words: Active Pharmaceutical ingredients, manufacturing, growth and formulations.
Bio - Associate Professor V. Y. John
V. Y. John is an Associate Professor in Business Management at Aristotle P. G. College, affiliated to Osmania University, Hyderabad, India. He has fifteen years of teaching experience in the area of finance apart from having worked in the industry for two years in the area of finance and accounts. He has recently published two papers on pharmaceutical industry in India.
PPN 050 - Understanding the TRIPs plus trend and access to medicines: a long view
Dr Valbona Muzaka
Bio -Dr Valbona Muzaka
Dr. Valbona Muzaka is Lecturer in Global Politics at the University of Southampton. Dr Muzaka has just finished writing a book on the politics of intellectual property rights and access to medicines, forthcoming (Palgrave). For full record of publications and research interests.
PPN 063 - TRIPping towards legitimacy? - A Public Health Norm in the World Trade Organization
Mr Dean Coldicott
Bio - Mr Dean Coldicott
Dean Coldicott is a Lecturer in International Relations at the School of International and Political Studies, Deakin University. Dean's research interests are in International Organisations, Global Governance, and International Political Economy with his PhD thesis titled 'Trading in Global Governance: The World Trade Organization and Non-Trade Norms' currently in the final stages of preparation for examination at the University of Melbourne.
PPN 064 - Analysing the issues in evergreening in the pharmaceutical sector from the developing countries' perspective
Ms Vinita Krishna
Keywords: TRIPS; Patents; Evergreening; Novartis; Access to Medicines; Inventiveness
Bio - Ms Vinita Krishna
Vinita Krishna is a DST trained IPR Scientist, who has worked with Indian Council of Medical Research and Gene Campaign an NGO, in New Delhi Her publications include research reviews/reports and articles on various issues of IPR. Currently, while pursuing a course in IPR,she is working as an independent researcher, presenting papers in seminars and conferences. Some of her recent work includes TRIPS-CBD relationship, medicinal plants and biopiracy, benefit sharing mechanism, farmers' right and plant genetic resources.
PPN 065 - Novartis And Legal Battle for Access to Medicines
Dr Gopal Dabade
Bio - Dr Gopal Dabade
PPN 066 - Has Life become cheap when Drugs are costly?: an enquiry in the issue of Public Health in the Post Doha Round
Assistant Professor Nalin Bharti
Key words: TRIPS, Public health, Doha Round, Drug famine, trade concessions.
Bio - Assistant Professor Nalin Bharti
Nalin Bharti (Ph.D, JNU) is currently an Assistant Professor in the Department of Humanities and Social Science at IIT Patna. He was awarded doctorate from School of International Studies, Jawaharlal Nehru University in 2005. His pre and post doctoral employment includes, visiting faculty in colleges at University of Delhi during 2000 to 2005, Research Associate in 12th Finance Commission, Government of India in 2004 and Lecturer Law and Economics at NALSAR University of Law, Hyderabad (2006-2008) and Hidayatullah National Law University, Raipur (2005-06). His recent Book is Privatization Unbound: Experiences in Bangladesh and India, Bookwell, 2009, New Delhi.
PPN 067 - Human Capital Management Strategies: A Survey of the Indian LifeSciences Industry
Ms Ritu Kamal*, Dr Devesh Kapur** & Dr Pankaj Chandra***
Bio - Ms Ritu Kamal, Dr Devesh Kapur & Dr Pankaj Chandra
Ritu is a Stanford India Biodesign Fellow (2010) and a former Research Associate at the Center for the Advanced Study of India, University of Pennsylvania. Her work focuses on the lifesciences sector in India, specifically in the area of low cost medical devices. She has a BS from Princeton University and a MS from the University of Pennsylvania.
Devesh Kapur, PhD, is the Director of the Center for the Advanced Study of India. He is Associate Professor of Political Science at the University of Pennsylvania, and holds the Madan Lal Sobti Professorship for the Study of Contemporary India.
Pankaj Chandra, PhD, is the Director of the Indian Institute of Management, Bangalore, where he has also been a Professor of Operations and Technology Management since 2007.
PPN 069 - Free Trade Agreements, TRIPS-Plus and Access to Health: The Arab World's Experience
Dr Mohammed El Said
Bio - Dr Mohammed El Said
El Said works as a lecturer at Lancashire Law School. El Said is a qualified solicitor under the Jordanian Bar. He worked as a consultant on IP issues with leading media organizations in the Middle East and for other international organizations including the UNDP, WIPO, and WHO. El Said is the author of the book The Development of Intellectual Property Protection in the Arab World.
PPN 070 - In Transit (Patent) Infringement Trouble Under TRIPS and Beyond
Dr Cynthia M. Ho
Bio - Dr Cynthia M. Ho
Dr Cynthia M. Ho have a dedicated interest and scholarly agenda concerning access to medicine in the global economy. She has published number of articles focusing on TRIPS and TRIPS plus agreements. In addition, I am working on a book under contract with Oxford University Press focused on this important issue.
PPN 071 - Influence of Pharmaceutical Trade and Regulations on Medicine's Affordability in Developing Countries
Mr Vishwajeet Mohan* & Mr Vikas Garg**
Bio - Mr Vishwajeet Mohan, Mr Vikas Garg
Mr Vishwajeet Mohan is Officer - Business Development, Shasun Research Centre, Chennai. He is involved in preparation of pharmaceutical market & regulatory reports and has published an international article on Indian pharma industry.
Mr Vikas Garg is a senior researcher at Medtrack Datamonitor, India. He has completed his M.S. (Pharm) in Pharmacology & Toxicology from NIPER and has carried out his research projects in AIIMS and IICT. His field of interest is pharmaceutical market and regulations of low income countries.
PPN 074 - Path Dependence to Path Creation: Evolving Dynamic Capabilities of Indian Pharmaceutical Companies
Mr Suresh Dasari & Mr Amalesh Sharma
Bio - Mr Suresh Dasari & Mr Amalesh Sharma
Suresh Dasari is an academic associate at Indian School of Business, Hyderabad. He researches in business strategies of firms in emerging markets. He received his Master of Business Administration (M.B.A.) degree from Indian Institute of Technology Madras,Chennai.
Amalesh Sharma is an academic associate at Indian School of Business, Hyderabad. His research interest includes marketing and competitive strategy. He is graduated from Delhi University and MBA from Mumbai. He has presented more than 15 research papers in International Conferences.
PPN 075 - Impact of Trade and TRIPS on Affordability of Medicine in Tanzania
Mr Deepak Kumar Jena
Bio - Mr Deepak Kumar Jena
Deepak Kumar Jena is an MS (Pharm) from the National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad. He is currently working as a research analyst (International Markets) at Pharmaceuticals Exports Promotion Council (Pharmexcil), and is engaged in research on the regulatory approvals/procedures of various countries. Born in 1983, Mr. Jena received his Bachelor's in Pharmacy from Sri Jayadev College of Pharmaceutical Sciences, Bhubaneshwar, Orissa. He was also a topper in the national and state-level competitive examinations such as the Graduate Aptitude Test Examination (GATE) 2007, with an All India Rank of 67, and he stood 3rd in the Orissa Joint Entrance Examination.
PPN 076 - Impact of European Union on Affordability of Medicine in African LDCs
Mr Poduri Balaram
Bio - Mr Poduri Balaram
Mr Poduri Balaram is currently Assistant Director of Pharmexcil (Pharmaceuticals Export Promotion Council of India, set up by Government of India). He holds a Masters Degree in Business Administration with 16 years work experience in various positions such as Deputy Manager of a business consulting company and Assistant Professor with a specialization in foreign trade and has worked in an exports organization. His research experience includes several consulting projects for various Indian business houses, Indian government & trade associations and a foreign export promotion agency such as the Ministry of Commerce, the Ministry of External Affairs, the Japanese External Trade Organization, the Confederation of Indian Industry, UshaCom RPG, etc. He has also undergone several training programs from Indian Institute of Foreign Trade and one International Training program on Intellectual Property Rights at Korea.
PPN 080 - Pharmaceutical Manufacturing in South Challenges and Scope
Mr. Ajinkya B. Badwe & Prof Amit A. Kane
Bio - Mr. Ajinkya B. Badwe & Prof Amit A. Kane
Mr. Ajinkya. B Badwe from MITCON Institute of Management, Pune completed B. Pharm from Pune University and has done his MBA in Pharmaceutical Management.
Prof Amit. A Kane worked 22 years with Merck as Manager in Pharma sales and distribution, Presently a Prof in Pharmaceutical management in MITCON.
PPN 081 - Access to Medicines and Pharma Industry in the aftermath of TRIPS: A transnational perspective
Ms Akanksha Mishra & Ms Shehnaz Ahmed
Bio - Ms Akanksha Mishra & Ms Shehnaz Ahmed
Ms Akanksha Mishra is 4th year student of B.A.LL.B (Hons) at Dr Ram Manohar Lohia National Law University, Lucknow, India. Her areas if interested are in Intellectual Property Rights, Human Rights, and Environmental Laws.
Ms Shehnaz Ahmed is 4th year student of B.A.LL.B (Hons) at Dr Ram Manohar Lohia National Law University, Lucknow, India. She is the Convenor, of the Journal Committee, Executive Editor of RMLNLU Law Review and her areas if interested are in Constitutional Law, Intellectual Property Law, Law of Arbitration, Women Rights, & Criminal Law.
PPN 082 - Role of Science Parks and Technology Business Incubators in Improving Healthcare Access and Needs
Dr Jitendra Kumar* & Ms Nirupama Lal
Bio - Dr Jitendra Kumar
Dr Jitendra Kumar is a Vice-President of Life Science incubator at IKP Knowledge Park, Hyderbad. He holds PhD (Biotechnology) degree from Institute of Microbial Technology, Chandigarh and received Post Doctoral training in Ohio State University, Columbus OHIO (USA) He also holds a MBA degree from Fisher College of Business at Ohio State University, USA.
PPN 085 - Impact of Post-Trips Scenario: Drug Patents v. Access to Life
Mr. Ravi K. Tripathi & Mr. Sudeep Shrivastava
Key Words: TRIPS, Pharmaceutical Industry, Product Patent, developing countries, drug prices
Bio - Mr. Ravi K. Tripathi & Mr. Sudeep Shrivastava
Ravi K. Tripathi is an associate fellow with Centre for International Sustainable development Law (CISDL) based in Montreal. He has presented his research findings in numerous national and International seminars besides being invited as speaker by various institutes. He has also worked with leading Indian law firms and is currently discharging functions as coordinator of Youth Initiative Network in Lucknow.
Sudeep Shrivastava is a fourth year student of B.A. LL.B. (Hons.) program at National Law University (Lucknow).
PPN 086 - Implication of TRIPS Agreement on the Pharmaceutical Sector of South Asia
Ms Arundhati Sharma
Bio - Ms Arundhati Sharma
Arundhati Sharma is a Research Scholar in the South Asian Division of School of International Studies, Jawaharlal Nehru University, New Delhi. She completed Bachelors' and Masters' in Political Science from Delhi University and currently pursuing M. Phil.
PPN 090 - Dynamics of Lobbies and Interest Groups in Indian Pharmaceutical Sector
Mr Santhosh M. R.
Bio - Mr Santhosh M. R.
Presently working with Centre for Trade and Development (Centad) an independent, not-for-profit organisation that carries out policy research and advocacy on issues around trade and development, with a focus on South Asia. Mr Santhosh M. R. joined Centad in July 2008 as an associate fellow and since then he has been working in the area of public health research and advocacy. Before Joining Centad he worked with the Delhi Team of Tracing Pharmaceuticals in South Asia (TPSA) project, which was headed by Prof. Roger Jeffery, University of Edinburgh, Scotland. Apart from this, he is doing Ph.D from Centre of Social Medicine and Community Health, School of Social Sciences, Jawaharlal Nehru University (JNU), New Delhi. He has an M.Phil degree from the Centre of Social Medicine and Community Health, School of Social Sciences, Jawaharlal Nehru University (JNU), The title of his M.Phil Dissertation is "The Political Economy of the Indian Drugs and Pharmaceutical Sector: A Preliminary Enquiry."
PPN 091 - Compulsory Licensing As Public Policy Intervention: Case Of Pharmaceutical Industry
Dr Shishir K. Jha* & Mr Babu Paul**
Bio - Dr Shishir K. Jha & Mr Babu Paul
Shishir K. Jha is an Associate Professor at the Shailesh J. Mehta School Of Management, IIT Bombay, where he has been working since 2001. He earned his Phd, MBA and MA [International Relations] from Syracuse University, New York. His research interests are broadly in the areas of international business, Intellectual Property and the public domain and open innovation.
Babu Paul is an ABD [all but dissertation] Research Scholar at the Humanities and Social Science Department, IIT Bombay. His work is on the use of compulsory licensing as a public policy mechanism.
PPN 093 - Drug Price Controls and Access to Medicines in India
Dr Prabodh Malhotra
Bio - Dr Prabodh Malhotra
Prabodh was born and brought up in India, lived in Austria and Germany in the 1970s, and migrated to Australia in 1980. Before returning to study in the 1990s, Prabodh worked with what was then known as the Victorian Railways. Dr. Prabodh Malhotra did his MIB from Swinburne University and completed PhD from Victoria University. Subsequent to completing his Masters in International Business, he taught International Business, International Trade Strategies, Transnational Marketing, Microeconomics and Foundations of Management at Swinburne University. Since finishing his PhD in Economics, Prabodh has been working at the Centre for Strategic Economic Studies, Victoria University.
PPN 098 - Globalizing health tourism in South Asia: An issue of accessibility and affordability of medicines
Dr Rajesh K
Bio - Dr Rajesh K
Rajesh K, post graduated in Economics from University of Hyderabad he has done Ph.D from Cochin University, thesis entitled as 'Coastal Tourism in Kerala: Its Impact on Economy and Environment'. Worked as a Faculty at ICFAI National College, Thrissur, Kerala from 2004 to 2009. Current profile is Guest Faculty at Cochin University. UGC/NET in Economics, which was held in June 2005, was also qualified.
PPN 099 - The Problems of Pharmaceutical Patents and Potential Solutions
Mr Philip Soos
Bio - Mr Philip Soos
Philip Soos is a Masters student at Deakin University. He is currently researching the costs and alternatives to pharmaceutical patents to establish whether patents really are the best option to finance pharmaceutical research and development. Philip also has MBA and IT degrees from RMIT University and Swinburne University of Technology, respectively.
Video footage was taken at the conference. To request access, please contact the Centre
Conference Welcome Address by
Professor Manohar Rao – Conference Co‐Chair
Professor G. Nancharaiah – Dean of the School of Social Sciences
Professor J.V.M. Sarma – Head of the Department of Economics
Ms Ravneet Pawha – Country Director Deakin (India)
Dr Hans Lofgren – Conference Co‐Chair
Opening Address by Professor Seyed E. Hasnain, Vice‐Chancellor, University of Hyderabad, Honorary Conference Chair
Part 2-1 & Part 2 -2
Opening Address by Professor Seyed E. Hasnain, Vice‐Chancellor, University of Hyderabad, Honorary Conference Chair
Professor D. Balasubramanian (L. V. Prasad Eye Institute) - "The birth and growth of the pharma and biotech industry in Andhra Pradesh: a ringside view"
Dr Mira Shiva (Initiative for Health and Equity in Society) -"Access to medicines, IPR and public health"
Part 3-1 & Part 3-2 - &Part 3.3 Dr Usha Ramanathan (Centre for the Study of Developing Societies) -"Pharmaceutical production: risk, responsibility and reparation"
Part 3.4 & Part 3.5
Cultural Program Day 1
Panel 1: Access to ARVs in Sub‐Saharan Africa: implications of the patents amendment bill in India
Part 5 & Part 6 & Part 7
Panel 5: Alternative R&D funding models: should the IPR system be abandoned?
Part 8 & Part 10
Panel 3: The environmental, social and political dimensions of pharmaceutical manufacturing
Keynote Addresses: James Love (Knowledge Ecology International, USA) & Anand Grover (United Nations) "The future of access to medicines"
Part 12 & Part 13 & Part 11
Keynote Address : Professor P. M. Bhargava (Founding director of the Centre for Cellular and Molecular Biology) -"Medical and health care scenario in 2050: where India can contribute"
Cultural Program Day 2
Professor Seyed E. Hasnain
University of Hyderabad
Honorary Conference Chair
Dr Hans Lofgren
Professor J. Manohar Rao
University of Hyderabad
Dr G. VijayUniversity of Hyderabad
Mr Dean Coldicott
Mrs Chippy Kurian Sunil
Centre for Citizenship and Globalisation, Deakin University